| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/29/2007 | US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 05/29/2007 | CA2341685C Secreted renilla luciferase |
| 05/29/2007 | CA2236998C Tissue-specific and target rna-specific ribozymes |
| 05/29/2007 | CA2206265C Process for reducing rna concentration in a mixture of biological material using diatomaceous earth |
| 05/24/2007 | WO2007059473A2 Methods for the production and purification of adenoviral vectors |
| 05/24/2007 | WO2007059372A2 Use of chloroquine to treat metabolic syndrome |
| 05/24/2007 | WO2007059303A2 Compositions for coordinated vegf and pdgf expression, and methods of use |
| 05/24/2007 | WO2007059298A2 Chimeric immunoreceptor useful in treating human cancers |
| 05/24/2007 | WO2007059103A2 Serum response factor and myocardin control alzheimer cerebral amyloid angiopathy |
| 05/24/2007 | WO2007059030A2 Llo-encoding dna/nucleic acid vaccines and methods comprising same |
| 05/24/2007 | WO2007059010A2 Stem cell factor therapy for tissue injury |
| 05/24/2007 | WO2007058992A2 Mutations and polymorphisms of hdac6 |
| 05/24/2007 | WO2007058991A2 Mutations and polymorphisms of c-abl |
| 05/24/2007 | WO2007058527A2 Inducible expression systems |
| 05/24/2007 | WO2007058384A1 Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same |
| 05/24/2007 | WO2007058381A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | WO2007057897A2 Pharmaceutical composition and method for regulating abnormal cellular proliferation |
| 05/24/2007 | WO2007057062A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | WO2007056861A1 Sirna silencing of influenza virus gene expression |
| 05/24/2007 | WO2007056847A1 Stabilizing formulations for recombinant viruses |
| 05/24/2007 | WO2007033221A3 Methods and compositions for inhibition of immune responses |
| 05/24/2007 | WO2006135431A3 Inhibition of metallo-beta-lactamase by rna |
| 05/24/2007 | WO2006130855A9 Method of targeted gene delivery using viral vectors |
| 05/24/2007 | WO2006125001A3 Compositions and methods related to the intracellular effects of intracellular domains of delta1 and jagged1 |
| 05/24/2007 | WO2006092782A3 Methods and compositions for modulating body weight and for treating weight disorders and related diseases |
| 05/24/2007 | WO2006015127A3 Treating cardiovascular tissue |
| 05/24/2007 | WO2005097205A8 Dna virus microrna and methods for inhibiting same |
| 05/24/2007 | US20070117774 Nonmalignant B lymphocyte cell comprising a plasmid vector; DNA vaccination |
| 05/24/2007 | US20070117773 Telomerase-inhibiting ENA oligonucleotide |
| 05/24/2007 | US20070117772 Methods for slowing familial ALS disease progression |
| 05/24/2007 | US20070117771 VGLUT-specific dsRNA compounds |
| 05/24/2007 | US20070117770 Human ribosomal DNA (rDNA) and ribosomal RNA (rRNA) nucleic acids and uses thereof |
| 05/24/2007 | US20070117769 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase |
| 05/24/2007 | US20070117768 Arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases |
| 05/24/2007 | US20070117767 siRNA Molecules and Method of Suppressing Gene Expression With the Use of the Same |
| 05/24/2007 | US20070117766 Vigilant cells |
| 05/24/2007 | US20070117747 Treating disorders of the nervous system |
| 05/24/2007 | US20070117746 Treatment of viral infections |
| 05/24/2007 | US20070117202 Novel nucleic acid molecule |
| 05/24/2007 | US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 05/24/2007 | US20070117166 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117138 Splice variant cannabinoid receptor (cb1b) |
| 05/24/2007 | US20070117098 'signalin' family of TGFbeta signal transduction proteins and uses related thereto |
| 05/24/2007 | US20070116776 Particulate drug-containing products and method of manufacture |
| 05/24/2007 | US20070116767 Chitosan-microparticles for ifn gene delivery |
| 05/24/2007 | US20070116733 Surface immobilised multilayer structure of vesicles |
| 05/24/2007 | US20070116726 Immunisation against Chlamydia pneumoniae |
| 05/24/2007 | US20070116710 Methods of treating hemolytic anemia |
| 05/24/2007 | US20070116692 Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells |
| 05/24/2007 | US20070116691 Conditionally immortalized long-term stem cells and methods of making and using such cells |
| 05/24/2007 | US20070116690 Method for the generation of antigen-specific lymphocytes |
| 05/24/2007 | US20070116689 LIM mineralization protein splice variants |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116687 Method of modulating cellular transmigration and agents for use therein |
| 05/24/2007 | US20070116686 Method for separating precursor cells producing gabaergic neuron alone |
| 05/24/2007 | US20070116685 Endothelial progenitor cells that express CD31 and c-kit, and not more than one percent express Tie-2 antigen; cell therapy for eye disorders |
| 05/24/2007 | US20070116675 Drug and method for proliferating natural killer cells |
| 05/24/2007 | US20070116673 fusion proteins; membrane proteins; cancer, metastasis |
| 05/24/2007 | US20070116672 Treatment of rheumatic diseases |
| 05/24/2007 | US20070116671 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 05/24/2007 | US20070116670 providing a medicament for the therapy of YB-1 positive diseases, in particular of tumor diseases; expressing a gene or gene fragment in a tumor cell |
| 05/24/2007 | CA2630349A1 Stabilizing formulations for recombinant viruses |
| 05/24/2007 | CA2630348A1 Inducible expression systems |
| 05/24/2007 | CA2629786A1 Human bocavirus and methods of diagnosis and treatment |
| 05/24/2007 | CA2629775A1 Stem cell factor therapy for tissue injury |
| 05/24/2007 | CA2629749A1 Chimeric immunoreceptor useful in treating human cancers |
| 05/24/2007 | CA2626092A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/23/2007 | EP1788394A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1788082A1 Nucleic acid construct |
| 05/23/2007 | EP1786905A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 05/23/2007 | EP1786474A2 Combined gene therapy for the treatment of macroscopic gliomas |
| 05/23/2007 | EP1786473A2 Treatment of parkinson's disease and related disorders |
| 05/23/2007 | EP1786472A2 Antisense modulation of apolipoprotein b expression |
| 05/23/2007 | EP1786470A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 05/23/2007 | EP1786466A2 Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors |
| 05/23/2007 | EP1308512B1 Novel proteins and dnas thereof |
| 05/23/2007 | EP1109926B1 Condensed plasmid-liposome complex for transfection |
| 05/23/2007 | EP1090146B1 Uses of dna-pk |
| 05/23/2007 | EP1019074B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/23/2007 | EP0970203B1 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease in humans |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1968959A 流行性感冒治疗 Influenza treatment |
| 05/23/2007 | CN1968717A Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 05/23/2007 | CN1968716A Methods of treating lung diseases |
| 05/23/2007 | CN1968608A Improved modalities for the treatment of degenerative diseases of the retina |
| 05/23/2007 | CN1966689A BCG vaccine expression vector and its construction |
| 05/23/2007 | CN1966684A Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 05/23/2007 | CN1966683A Recombinant adenovirus for expression of novel tumour suppressor gene p53 |
| 05/23/2007 | CN1966084A Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
| 05/23/2007 | CN1966083A Tumor vaccine of fusion gene and construction method thereof |
| 05/23/2007 | CN1966082A Genetic medicine for preventing and treating cancer of colon and rectum, preparation process and use thereof |
| 05/23/2007 | CN1966081A Bivalent DNA vaccine for Japanese blood fluke and preparation process thereof |
| 05/23/2007 | CN1317389C Structure of antisense digonucleotide for inhibiting fibronectin expression and use |
| 05/23/2007 | CN1317320C Polyethylene imine nanometer gel and its uses |
| 05/23/2007 | CN1317300C Glycine-riched protein and active fragment and use thereof |
| 05/23/2007 | CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 05/23/2007 | CN1317034C Nuclec acid adjuvants |
| 05/22/2007 | US7220891 Feline bronchioloalveolar lung carcinoma xenograft and cell line |